Source: Head & neck. Unidade: FM
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA;ECONOMIA), CUSTO ECONÔMICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRENTANI, Alexandra e CASTRO, Gilberto de e FEDERICO, Miriam H. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil. Head & neck, v. 33, n. 8, p. 1199-1205, 2011Tradução . . Disponível em: https://doi.org/10.1002/hed.21601. Acesso em: 04 out. 2024.APA
Brentani, A., Castro, G. de, & Federico, M. H. (2011). Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil. Head & neck, 33( 8), 1199-1205. doi:10.1002/hed.21601NLM
Brentani A, Castro G de, Federico MH. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil [Internet]. Head & neck. 2011 ; 33( 8): 1199-1205.[citado 2024 out. 04 ] Available from: https://doi.org/10.1002/hed.21601Vancouver
Brentani A, Castro G de, Federico MH. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil [Internet]. Head & neck. 2011 ; 33( 8): 1199-1205.[citado 2024 out. 04 ] Available from: https://doi.org/10.1002/hed.21601
